Cargando…
HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers
BACKGROUND: HCQ is a commonly recommended drug for the prophylaxis of COVID-19. One of its rare side-effect includes QTc prolongation. METHODS: This was a prospective, cross sectional and observational study conducted on Hydroxychloroquine (HCQ) among Healthcare Workers (HCWs) at Max Super Specialit...
Autores principales: | Jha, Sujeet, Batra, Nitish, Siddiqui, Samreen, Yadav, Ashutosh, Misra, Archa, Loomba, Menka, Sethi, Sumeet, Waghdhare, Swati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654303/ https://www.ncbi.nlm.nih.gov/pubmed/33714413 http://dx.doi.org/10.1016/j.ihj.2020.11.005 |
Ejemplares similares
-
GCK Gene Screening and Association of GCK Variants With Gestational Diabetes in North Indian Population
por: Siddiqui, Samreen, et al.
Publicado: (2018) -
Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards
por: Garg, Shivani, et al.
Publicado: (2023) -
Molecular Insights into the MAPK Cascade during Viral Infection: Potential Crosstalk between HCQ and HCQ Analogues
por: Mohanta, Tapan Kumar, et al.
Publicado: (2020) -
Quantitative Fundus Autofluorescence in HCQ Retinopathy
por: Greenstein, Vivienne C., et al.
Publicado: (2020) -
The ‘myth of Hydroxychloroquine (HCQ) as post-exposure prophylaxis (PEP) for the prevention of COVID-19’ is far from reality
por: Dhibar, Deba Prasad, et al.
Publicado: (2023)